Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cabo Verde Business Journal.
Press releases published on May 14, 2025
Acrivon Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights
GlobeNewswire
·
May 14, 2025
Corporate R…
Aardvark Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights
GlobeNewswire
·
May 14, 2025
Phase 3 HERO trial of ARD-101 for the treatment of hyperphagia associated with Prader-Willi Syndrome (PWS); data readout expected in early 2026 $151.3 million in cash, cash equivalents, and short-term investments supports projected operations into 2027 SAN …
GENFIT: Publication of the 2025 Extra-Financial Performance Report (fiscal year 2024)
GlobeNewswire
·
May 14, 2025
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 14, 2025- GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today …
USA Rare Earth Reports its First Quarter 2025 Financial Results
GlobeNewswire
·
May 14, 2025
STILLWATER, Okla., May 14, 2025 (GLOBE NEWSWIRE) -- USA Rare Earth, Inc. (Nasdaq: USAR) (“USAR” or the “Company”) today announced its financial results for the first quarter ended March 31, 2025. First Quarter Highlights Merged with Inflection Point and …
IREN Reports Q3 FY25 Results
GlobeNewswire
·
May 14, 2025
28% Growth in Profit After Tax Horizon 1 AI Data Center on Track for H2 2025 Pausing Mining Expansion at 50 EH/s to Focus on AI Opportunities SYDNEY, May 14, 2025 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ: IREN) (together with its subsidiaries, “IREN” or “ …
Silo Pharma Selects Veloxity Labs for Bioanalytical IND-Enabling Study for our Novel Intranasal PTSD Therapy, SPC-15
GlobeNewswire
·
May 14, 2025
SARASOTA, FL, May 14, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced that it has engaged Veloxity …
The Oncology Institute Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance
GlobeNewswire
·
May 14, 2025
CERRITOS, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its three months …
Fossil Group, Inc. Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 14, 2025
RICHARDSON, Texas, May 14, 2025 (GLOBE NEWSWIRE) -- First quarter worldwide net sales totaled $233 million Gross margin expanded 890 basis points to 61.3% First quarter operating loss of $7 million; constant currency adjusted operating income of $10 …
Lulus Reports First Quarter 2025 Results
GlobeNewswire
·
May 14, 2025
Significant Improvement in Liquidity with $1.4M Increase in Cash Provided by Operating Activities and $1.8M Increase in Free Cash Flow, Both Compared to Q1’24 Reduced Total Debt by $3.0M and Net Debt by $7.2M During Q1’25 CHICO, Calif., May 14, 2025 (GLOBE …
Hawkins, Inc. Reports Fourth Quarter and Fiscal Year 2025 Results
GlobeNewswire
·
May 14, 2025
ROSEVILLE, Minn., May 14, 2025 (GLOBE NEWSWIRE) -- Hawkins, Inc. (Nasdaq: HWKN) today announced fourth quarter and full-year results for its fiscal year ended March 30, 2025. Fourth Quarter Fiscal Year 2025 Highlights: Record fourth quarter sales of $245.3 …
Bannix Acquisition Corp. Announces Monthly Extension to Complete its Initial Business Combination
GlobeNewswire
·
May 14, 2025
WILMINGTON, Del., May 14, 2025 (GLOBE NEWSWIRE) -- Bannix Acquisition Corp. (“Bannix”) announced today that its board of directors (the “Board”) has decided to extend the date by which Bannix must consummate an initial business combination (the “Deadline …
Castor Maritime Inc. Reports Fourth Quarter and Full Year Results for 2024
GlobeNewswire
·
May 14, 2025
LIMASSOL, Cyprus, May 14, 2025 (GLOBE NEWSWIRE) -- Castor Maritime Inc. (NASDAQ: CTRM) (“Castor” or the “Company”), a diversified global shipping and energy company, today announced its results for the three months and year ended December 31, 2024. …
Castor Maritime Inc. Announces Availability of its 2024 Annual Report on Form 20-F
GlobeNewswire
·
May 14, 2025
LIMASSOL, Cyprus, May 14, 2025 (GLOBE NEWSWIRE) -- Castor Maritime Inc. (NASDAQ: CTRM), (“Castor”, or the “Company”), a diversified global shipping and energy company, announces that the Company’s annual report on Form 20‐F (the “Annual Report”), which …
Aterian Reports 2025 First Quarter Financial Results
GlobeNewswire
·
May 14, 2025
SUMMIT, N.J., May 14, 2025 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”), a consumer products company, today announced financial results for the first quarter ended March 31, 2025 (“Q1 2025”). The Company also provided an …
The Oncology Institute Welcomes Dr. Jeff Langsam as Chief Clinical Officer
GlobeNewswire
·
May 14, 2025
CERRITOS, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI”), one of the largest value-based oncology groups in the United States, announced today that Dr. Jeffrey Langsam will assume the role of enterprise Chief …
Shimmick Corporation Announces First Quarter 2025 Results
GlobeNewswire
·
May 14, 2025
IRVINE, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Shimmick Corp. (NASDAQ: SHIM), a leading infrastructure solutions provider in water, climate resilience, energy transition and sustainable transportation, today announced financial results for the first …
Zentalis Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Progress
GlobeNewswire
·
May 14, 2025
First patient dosed in DENALI Part 2a clinical trial of azenosertib in patients with Cyclin E1+ PROC Topline data from DENALI Part 2 anticipated by year end 2026 with the potential to support an accelerated approval, subject to FDA feedback $332.5 million …
Jade Biosciences Reports First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
May 14, 2025
Completed reverse merger and commenced trading on Nasdaq as JBIO Closed financing, raising approximately $300 million to date, providing cash runway through 2027 Lead candidate JADE101 expected to enter the clinic in second half of 2025, with interim …
Nasdaq Announces 2025 Annual Meeting of Shareholders
GlobeNewswire
·
May 14, 2025
NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) has scheduled its 2025 Annual Meeting of Shareholders for June 11, 2025, at 8:00 AM ET. The virtual meeting website can be accessed 15 minutes prior to the meeting start by visiting: …
Latham Group, Inc. to Participate at Upcoming Conferences in May 2025
GlobeNewswire
·
May 14, 2025
LATHAM, N.Y., May 14, 2025 (GLOBE NEWSWIRE) -- Latham Group, Inc. (Nasdaq: SWIM), the largest designer, manufacturer, and marketer of in-ground residential swimming pools in North America, Australia, and New Zealand, today announced that management will …